0 Commentarii
0 Distribuiri
161 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Cold Agglutinin Disease Market – What Advances Are Transforming Treatment of Rare Blood Disorders?"Cold Agglutinin Disease Market Summary: According to the latest report published by Data Bridge Market Research, the Cold Agglutinin Disease Market CAGR Value The global cold agglutinin disease market size was valued at USD 145.35 billion in 2025 and is expected to reach USD 592.41 billion by 2033, at a CAGR of 19.20% during the forecast period...0 Commentarii 0 Distribuiri 164 Views 0 previzualizare
-
Rare Hemophilia Factors Market to Reach USD 247 Million by 2031 | CAGR 3.1%According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031. Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...0 Commentarii 0 Distribuiri 577 Views 0 previzualizare
-
Will EPO Drugs Continue to Revolutionize Anemia Treatment?Global Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share CAGR Value The global erythropoietin (EPO) drugs market size was valued at USD 9.12 billion in 2024 and is expected to reach USD 22.60 billion by 2032, at a CAGR of 12.00% during the forecast period Global Erythropoietin (EPO) Drugs Market report is a...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
Sponsor
Sponsor